glp-1 nausea class action in west virginia GLP-1 Weight Loss Drugs and Gastrointestinal Injuries: West Virginia ends GLP-1 subsidy

GLP-1 medications may increase kidney stone risk through dehydration and uric acid changes, but individual risk depends on baseline kidney function, hydration status, and metabolic factors

New research suggests that around 10% of people carry genetic variations that help explain why.

The GLP-1 Market size was valued at USD 52.82 billion in 2025 and is expected to grow at a CAGR of 10.9% from 2026 to 2034.

Two of the most popular bariatric procedures, vertical sleeve gastrectomy (VSG) and Roux-en-Y gastric bypass (RYGB), are commonly considered metabolic surgeries because they are thought to affect metabolism in a weight lossindependent manner

The Key to Crushing Your Goals

Learn whether alternating between semaglutide and tirzepatide is safe, how their mechanisms differ, transition protocols, and what research says about cycling GLP-1 medications.